| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4975395 | Journal of the Franklin Institute | 2014 | 19 Pages |
Abstract
Peter Nowell is known for his discovery that a small terminal deletion on chromosome 22 is a consistent feature in leukemic cells from chronic myelogenous leukemia (CML) patients. This was the first direct evidence that a human cancer could be the result of a somatic (chromosomal) mutation, and paved the way for the development of a therapy that now cures 95% of individuals with CML.
Related Topics
Physical Sciences and Engineering
Computer Science
Signal Processing
Authors
Donald Silberberg,